Heart Health Supplements Market
Description
Heart Health Supplements Market Summary
The global heart health supplements market size was estimated at USD 10,264.8 million in 2025 and is expected to reach USD 16,434.8 million by 2033, growing at a CAGR of 6.2% from 2026 to 2033. Heart health supplements are natural and functional compounds designed to support cardiovascular wellness by improving blood circulation, reducing cholesterol levels, maintaining healthy blood pressure, and strengthening overall heart function.
Rising consumer awareness of preventive healthcare and the importance of maintaining cardiovascular health is a key factor driving demand for these supplements. The growing global emphasis on preventive healthcare is significantly influencing demand for heart health supplements. Consumers are increasingly shifting toward proactive health management, recognizing that early preventive measures can help reduce the risk of chronic conditions, particularly cardiovascular diseases. This change in mindset is driving higher adoption of supplements that support cholesterol management, blood pressure regulation, and overall vascular health, especially among aging populations and health-conscious consumers.
Furthermore, governments, healthcare organizations, and insurance providers are actively promoting preventive care through public health campaigns, workplace wellness programs, and incentives that encourage healthier lifestyles. These initiatives are increasing awareness of cardiovascular risks and the role of nutrition and supplementation in long-term heart health. For instance, in 2025, Allianz Partners launched its global “Paths to Prevention” campaign, which identified cardiovascular disease as a major chronic condition and focused on empowering individuals with practical lifestyle and nutrition-based strategies to lower long-term health risks. Collectively, these efforts are strengthening consumer confidence in preventive solutions and supporting sustained growth in the heart health supplements market.
In addition, digital channels and health-oriented platforms are playing an increasingly important role in improving consumer awareness. Greater access to online health information has enabled individuals to better understand the benefits of key ingredients such as omega-3 fatty acids, plant sterols, and antioxidants in supporting cardiovascular health. Educational content shared through websites, social media, and wellness apps is helping consumers make more informed supplement choices. Moreover, the rising adoption of wearable health devices and mobile applications that track metrics such as blood pressure and cholesterol levels is reinforcing preventive health behaviors. This growing digital health engagement is encouraging consumers to take a more proactive and data-driven approach to heart health management.
Cardiovascular diseases (CVDs) continue to be the leading cause of death globally, and their increasing prevalence is a major factor driving demand for heart health supplements. According to the World Health Organization (WHO), approximately 19.8 million people died due to cardiovascular conditions, accounting for around 32% of total global deaths, with heart attacks and strokes responsible for the majority of these cases. Recent global health reports and medical studies have consistently highlighted the growing burden of cardiovascular conditions, particularly across both developed and emerging economies. Rising incidence rates, combined with long-term lifestyle and demographic shifts, continue to place significant pressure on healthcare systems worldwide.
The rise in CVD incidence is closely linked to aging populations and the widespread adoption of unhealthy lifestyles. Factors such as physical inactivity, obesity, smoking, excessive alcohol consumption, and diets high in saturated fats and sodium continue to elevate cardiovascular risk levels. Data released in 2025 by the World Health Organization indicate a substantial increase in global obesity levels. In 2022, approximately one in eight individuals worldwide was affected by obesity. During the same year, an estimated 2.5 billion adults aged 18 years and above were classified as overweight, of whom nearly 890 million were living with obesity, highlighting the growing scale of weight-related health challenges globally.
Furthermore, emerging economies are also witnessing a surge in CVD cases, largely driven by rapid urbanization and lifestyle changes. For instance, according to the World Health Organization (WHO), India alone accounts for approximately one-fifth of global CVD deaths, with younger age groups showing higher incidence rates compared to Western countries. These trends highlight the urgent need for preventive interventions, making heart health supplements an attractive and accessible option for many consumers.
Thus, the rising prevalence of cardiovascular diseases worldwide, across both developed and developing nations, is a major factor fueling the heart health supplements market. This trend is expected to continue as aging populations expand, urbanization accelerates, and lifestyle-related risk factors become increasingly widespread.
Global Heart Health Supplements Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the heart health supplements market report on the basis of ingredient, form, application, distribution channel, and region:
The global heart health supplements market size was estimated at USD 10,264.8 million in 2025 and is expected to reach USD 16,434.8 million by 2033, growing at a CAGR of 6.2% from 2026 to 2033. Heart health supplements are natural and functional compounds designed to support cardiovascular wellness by improving blood circulation, reducing cholesterol levels, maintaining healthy blood pressure, and strengthening overall heart function.
Rising consumer awareness of preventive healthcare and the importance of maintaining cardiovascular health is a key factor driving demand for these supplements. The growing global emphasis on preventive healthcare is significantly influencing demand for heart health supplements. Consumers are increasingly shifting toward proactive health management, recognizing that early preventive measures can help reduce the risk of chronic conditions, particularly cardiovascular diseases. This change in mindset is driving higher adoption of supplements that support cholesterol management, blood pressure regulation, and overall vascular health, especially among aging populations and health-conscious consumers.
Furthermore, governments, healthcare organizations, and insurance providers are actively promoting preventive care through public health campaigns, workplace wellness programs, and incentives that encourage healthier lifestyles. These initiatives are increasing awareness of cardiovascular risks and the role of nutrition and supplementation in long-term heart health. For instance, in 2025, Allianz Partners launched its global “Paths to Prevention” campaign, which identified cardiovascular disease as a major chronic condition and focused on empowering individuals with practical lifestyle and nutrition-based strategies to lower long-term health risks. Collectively, these efforts are strengthening consumer confidence in preventive solutions and supporting sustained growth in the heart health supplements market.
In addition, digital channels and health-oriented platforms are playing an increasingly important role in improving consumer awareness. Greater access to online health information has enabled individuals to better understand the benefits of key ingredients such as omega-3 fatty acids, plant sterols, and antioxidants in supporting cardiovascular health. Educational content shared through websites, social media, and wellness apps is helping consumers make more informed supplement choices. Moreover, the rising adoption of wearable health devices and mobile applications that track metrics such as blood pressure and cholesterol levels is reinforcing preventive health behaviors. This growing digital health engagement is encouraging consumers to take a more proactive and data-driven approach to heart health management.
Cardiovascular diseases (CVDs) continue to be the leading cause of death globally, and their increasing prevalence is a major factor driving demand for heart health supplements. According to the World Health Organization (WHO), approximately 19.8 million people died due to cardiovascular conditions, accounting for around 32% of total global deaths, with heart attacks and strokes responsible for the majority of these cases. Recent global health reports and medical studies have consistently highlighted the growing burden of cardiovascular conditions, particularly across both developed and emerging economies. Rising incidence rates, combined with long-term lifestyle and demographic shifts, continue to place significant pressure on healthcare systems worldwide.
The rise in CVD incidence is closely linked to aging populations and the widespread adoption of unhealthy lifestyles. Factors such as physical inactivity, obesity, smoking, excessive alcohol consumption, and diets high in saturated fats and sodium continue to elevate cardiovascular risk levels. Data released in 2025 by the World Health Organization indicate a substantial increase in global obesity levels. In 2022, approximately one in eight individuals worldwide was affected by obesity. During the same year, an estimated 2.5 billion adults aged 18 years and above were classified as overweight, of whom nearly 890 million were living with obesity, highlighting the growing scale of weight-related health challenges globally.
Furthermore, emerging economies are also witnessing a surge in CVD cases, largely driven by rapid urbanization and lifestyle changes. For instance, according to the World Health Organization (WHO), India alone accounts for approximately one-fifth of global CVD deaths, with younger age groups showing higher incidence rates compared to Western countries. These trends highlight the urgent need for preventive interventions, making heart health supplements an attractive and accessible option for many consumers.
Thus, the rising prevalence of cardiovascular diseases worldwide, across both developed and developing nations, is a major factor fueling the heart health supplements market. This trend is expected to continue as aging populations expand, urbanization accelerates, and lifestyle-related risk factors become increasingly widespread.
Global Heart Health Supplements Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the heart health supplements market report on the basis of ingredient, form, application, distribution channel, and region:
- Ingredient Outlook (Revenue, USD Million, 2021 - 2033)
- Omega 3 Fatty Acids
- Coenzyme Q10
- Vitamins & Minerals
- Botanical
- Dietary Fibers
- Prebiotics
- Amino Acids
- Others
- Form Outlook (Revenue, USD Million, 2021 - 2033)
- Capsules
- Tablets
- Softgels
- Powders
- Gummies
- Liquids
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Cholesterol Management
- Triglyceride Reduction
- Blood Pressure Support
- Endothelial Function & Circulation
- Anti-inflammatory/Oxidative Stress
- Heart Energy & Performance
- Others
- Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Hypermarkets & Supermarkets
- Pharmacy & Drug Stores
- Specialty Store
- Online
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- Thailand
- South Korea
- Taiwan
- Malaysia
- Central & South America
- Brazil
- Middle East & Africa
- South Africa
Table of Contents
130 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR’s Internal Database
- 1.3.3. Secondary Materials & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Ingredient Outlook
- 2.3. Form Outlook
- 2.4. Application Outlook
- 2.5. Distribution Channel Outlook
- 2.6. Regional Outlook
- 2.7. Competitive Landscape Snapshot
- Chapter 3. Heart Health Supplements Market Variables and Trends
- 3.1. Market Introduction
- 3.2. Industry Value Chain Analysis
- 3.2.1. Profit Margin Analysis
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.3.3. Market Opportunities
- 3.3.4. Market Challenges
- 3.4. Industry Analysis Tools
- 3.4.1. Porter’s Five Forces Analysis
- 3.5. Market Entry Strategies
- Chapter 4. Heart Health Supplements Market: Consumer Behavior Analysis
- 4.1. Demographic Analysis
- 4.2. Consumer Trends & Preferences
- 4.3. Factors Affecting Buying Decisions
- 4.4. Consumer Product Adoption
- 4.5. Observations & Recommendations
- Chapter 5. Heart Health Supplements Market: Ingredient Estimates & Trend Analysis
- 5.1. Heart Health Supplements Market, By Ingredient: Key Takeaways
- 5.2. Ingredient Movement Analysis & Market Share, 2025 & 2033
- 5.3. Market Estimates & Forecasts by Ingredient, 2021 - 2033 (USD Million)
- 5.3.1. Omega 3 Fatty Acids
- 5.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.2. Coenzyme Q10
- 5.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.3. Vitamins & Minerals
- 5.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.4. Botanical
- 5.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.5. Dietary Fibers
- 5.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.6. Prebiotics
- 5.3.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.7. Amino Acids
- 5.3.7.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.8. Others
- 5.3.8.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- Chapter 6. Heart Health Supplements Market: Form Estimates & Trend Analysis
- 6.1. Heart Health Supplements Market, By Form: Key Takeaways
- 6.2. Form Movement Analysis & Market Share, 2025 & 2033
- 6.3. Market Estimates & Forecasts by Form, 2021 - 2033 (USD Million)
- 6.3.1. Capsules
- 6.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 6.3.2. Tablets
- 6.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 6.3.3. Softgels
- 6.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 6.3.4. Powders
- 6.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 6.3.5. Gummies
- 6.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 6.3.6. Liquids
- 6.3.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 6.3.7. Others
- 6.3.7.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- Chapter 7. Heart Health Supplements Market: Application Estimates & Trend Analysis
- 7.1. Heart Health Supplements Market, By Application: Key Takeaways
- 7.2. Application Movement Analysis & Market Share, 2025 & 2033
- 7.3. Market Estimates & Forecasts by Application, 2021 - 2033 (USD Million)
- 7.3.1. Cholesterol Management
- 7.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.2. Triglyceride Reduction
- 7.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.3. Blood Pressure Support
- 7.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.4. Endothelial Function & Circulation
- 7.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.5. Anti-inflammatory/Oxidative Stress
- 7.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.6. Heart Energy & Performance
- 7.3.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.7. Others
- 7.3.7.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- Chapter 8. Heart Health Supplements Market: Distribution Channel Estimates & Trend Analysis
- 8.1. Heart Health Supplements Market, By Distribution Channel: Key Takeaways
- 8.2. Distribution Channel Movement Analysis & Market Share, 2025 & 2033
- 8.3. Market Estimates & Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
- 8.3.1. Hypermarkets & Supermarkets
- 8.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.2. Pharmacy & Drug Stores
- 8.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.3. Specialty Store
- 8.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.4. Online
- 8.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.5. Others
- 8.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- Chapter 9. Heart Health Supplements Market: Regional Estimates & Trend Analysis
- 9.1. Regional Movement Analysis & Market Share, 2025 & 2033
- 9.2. North America
- 9.2.1. U.S.
- 9.2.1.1. Key country dynamics
- 9.2.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.2.2. Canada
- 9.2.2.1. Key country dynamics
- 9.2.2.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.2.3. Mexico
- 9.2.3.1. Key country dynamics
- 9.2.3.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.3. Europe
- 9.3.1. UK
- 9.3.1.1. Key country dynamics
- 9.3.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.3.2. Germany
- 9.3.2.1. Key country dynamics
- 9.3.2.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.3.3. France
- 9.3.3.1. Key country dynamics
- 9.3.3.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.3.4. Spain
- 9.3.4.1. Key country dynamics
- 9.3.4.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.4. Asia Pacific
- 9.4.1. China
- 9.4.1.1. Key country dynamics
- 9.4.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.4.2. India
- 9.4.2.1. Key country dynamics
- 9.4.2.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.4.3. Japan
- 9.4.3.1. Key country dynamics
- 9.4.3.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.4.4. Australia & New Zealand
- 9.4.4.1. Key country dynamics
- 9.4.4.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.4.5. Thailand
- 9.4.5.1. Key country dynamics
- 9.4.5.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.4.6. South Korea
- 9.4.6.1. Key country dynamics
- 9.4.6.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.4.7. Taiwan
- 9.4.7.1. Key country dynamics
- 9.4.7.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.4.8. Malaysia
- 9.4.8.1. Key country dynamics
- 9.4.8.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.5. Central & South America
- 9.5.1. Brazil
- 9.5.1.1. Key country dynamics
- 9.5.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.6. Middle East & Africa
- 9.6.1. South Africa
- 9.6.1.1. Key country dynamics
- 9.6.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
- Chapter 10. Heart Health Supplements Market: Competitive Analysis
- 10.1. Recent Developments & Impact Analysis by Key Market Participants
- 10.2. Company Categorization
- 10.3. Participant’s Overview
- 10.4. Financial Performance
- 10.5. Product Benchmarking
- 10.6. Company Market Share Analysis, 2025 (%)
- 10.7. Company Heat Map Analysis, 2025
- 10.8. Strategy Mapping
- 10.9. Company Profiles
- 10.9.1. Nestle Health Science
- 10.9.1.1. Company Overview
- 10.9.1.2. Financial Performance
- 10.9.1.3. Product Portfolios
- 10.9.1.4. Strategic Initiatives
- 10.9.2. Herbalife Nutrition Ltd.
- 10.9.2.1. Company Overview
- 10.9.2.2. Financial Performance
- 10.9.2.3. Product Portfolios
- 10.9.2.4. Strategic Initiatives
- 10.9.3. Amway Corp.
- 10.9.3.1. Company Overview
- 10.9.3.2. Financial Performance
- 10.9.3.3. Product Portfolios
- 10.9.3.4. Strategic Initiatives
- 10.9.4. GNC Holdings Inc.
- 10.9.4.1. Company Overview
- 10.9.4.2. Financial Performance
- 10.9.4.3. Product Portfolios
- 10.9.4.4. Strategic Initiatives
- 10.9.5. Nature’s Bounty Co
- 10.9.5.1. Company Overview
- 10.9.5.2. Financial Performance
- 10.9.5.3. Product Portfolios
- 10.9.5.4. Strategic Initiatives
- 10.9.6. NOW Foods
- 10.9.6.1. Company Overview
- 10.9.6.2. Financial Performance
- 10.9.6.3. Product Portfolios
- 10.9.6.4. Strategic Initiatives
- 10.9.7. Sanofi S.A.
- 10.9.7.1. Company Overview
- 10.9.7.2. Financial Performance
- 10.9.7.3. Product Portfolios
- 10.9.7.4. Strategic Initiatives
- 10.9.8. Bayer AG
- 10.9.8.1. Company Overview
- 10.9.8.2. Financial Performance
- 10.9.8.3. Product Portfolios
- 10.9.8.4. Strategic Initiatives
- 10.9.9. Nordic Naturals
- 10.9.9.1. Company Overview
- 10.9.9.2. Financial Performance
- 10.9.9.3. Product Portfolios
- 10.9.9.4. Strategic Initiatives
- 10.9.10. Thorne HealthTech Inc.
- 10.9.10.1. Company Overview
- 10.9.10.2. Financial Performance
- 10.9.10.3. Product Portfolios
- 10.9.10.4. Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
